ARVO Annual Meeting
May 3-7, 2026
Denver, USA
https://www.arvo.org/annual-meeting
News and Events
Subscribe to our press distribution list to receive the latest news about AMW.
Downloads
Upcoming
Events
BIO International Convention
June 22-25, 2026
San Diego, USA
https://convention.bio.org/
CRS (Controlled Release Society) Annual Meeting
July 6-9, 2026
Lisbon, Portugal
https://www.controlledreleasesociety.org/events/crs-2026-annual-meeting-exposition
CPHI South East Asia
July 8-10, 2026
Bangkok, Thailand
https://www.cphi.com/sea/en/attend/attend/why-attend.html
CPHI Milan
October 6-8, 2026
Milan, Italy
https://www.cphi.com/europe/en/exhibit/book-your-stand-milan.html
PODD – Partnership Opportunities in Drug Delivery
October 29-30, 2026
Boston, USA
https://poddconference.com/
BIO-Europe
November 9-11, 2026
Cologne, Germany
https://informaconnect.com/bioeurope/
Past
Events
Archive
AT Uro Congress
May 22-24, 2025
Vienna, Austria
International Partnering in Life-Sciences Society (IPLS)
September 29 – October 1, 2025
Berlin, Germany
https://ipls.online/events/
CPHI Frankfurt
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
PharmaSynergyRx
February 5-6, 2026
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2026/
EuroPLX
March 2-3, 2026
Lisbon, Portugal
https://www.raucon.com/euro-plx/euro-p-l-x-90
BIO-Europe Spring
March 23-25, 2026
Lisbon, Portugal
https://informaconnect.com/bioeurope-spring/
DCAT Week
March 23-26, 2026
New York City, USA
https://dcatweek.org/
PBP World Meeting
March 23-26, 2026
Prague, Czech Republic
https://worldmeeting.org/
analytica
March 24-27, 2026
Munich, Germany
https://analytica.de/de/muenchen/
Latest
News
In January 2014, AMW GmbH was able to conclude a semi-exclusive license and supply contract for its biodegradable goserelin implants with a multinational pharmaceutical company.
The contract applies to Southeast Asia, including China, Eastern Europe, Russia and some Western European countries. The agreements contain down payment payments of up to € 10 million, license payments in the double-digit percentage range, and an exclusive delivery agreement for AMW. The partner company will carry out further clinical developments for the contract area.
read moreAMW GmbH has been successfully certified by Tüv Süd to EN ISO 13485: 2012/AC: 2012
Nr.ISO Certificate: Q21-13.07.84140.001
Validity: from 07.10.2013 to 06.10.2016
Scope: Manufacture, quality control, quality assurance and distribution of medical devices in plaster form
Applied standard(s):
EN ISO 13485: 2012/AC: 2012
Medical devices
Quality management systems
Requirements for regulatory purposes
Obtaining unrestricted manufacturing permission for transdermal systems and drug implants
Type of inspection: General GMP inspection in accordance with Section 64 of the German Medicines Act (AMG), the provisions of the German Medicines and Drug Manufacturing Ordinance (AMWHV) and the EC-GMP Guide for the Acceptance of the New Manufacturing Rooms of AMW GmbH for the Production of Transdermal Systems, Verification of Systems for the Production of Clinical Test Samples and Manufacture of Market Goods for The Products: Transdermal Systems and Implants and for obtaining manufacturing authorisation for Market Goods.
read moreObtaining manufacturing permission for sterile products
General GMP inspection in accordance with Section 64 of the German Medicines Act (AMG), the provisions of the German Medicines and Drug Manufacturing Ordinance (AMWHV) and the EC-GMP Guide for the Acceptance of the New Manufacturing Rooms of AMW GmbH
read more